Fig. 5: EB-associated high NRM is reduced but not normalized by SEP.
From: Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication
Non-relapse mortality after d + 28 depending on EB and statin-based endothelial protection (SEP) (training cohort). a All patients including SOS/VOD. Hazard ratio (HR) of EB without SEP: 2.88 (95% CI 1.90–4.36, p < 0.001 compared with no EB), and 1.92 with SEP (1.11–3.35, p = 0.021 compared with no EB). b Excluding patients with SOS/VOD. HR of EB without SEP: 2.84 (1.75–4.63 p < 0.001 compared with no EB) and 2.01 with SEP (1.11–3.65, p = 0.022 compared with no EB).
